JAKARTA – In its pursue of new business pillars, PT Saratoga Investama Tbk (SRTG) seeks to seize opportunities in the healthcare and renewable energy sectors.

Until March 2023, SRTG was still faced with difficulties in securing gains from its investments, already losing IDR 5.1 trillion, contrasting to IDR 3.9 trillion of gains seen in Q1 2023.

Devin Wirawan, Director of Investment of Saratoga Investama, confirmed this setback. Almost 85% of SRTG’s portfolio is dominated by blue-chip companies, such as PT Merdeka Copper Gold Tbk (MDKA) and PT Adaro Energy Tbk (ADRO), whose performance are heavily influenced by fluctuating commodities’ price.

“Therefore, we wish to secure new business pillars, adding investments in non-natural-resources companies, including clean and renewable energy sector as well as healthcare,” Wirawan added.

Wirawan admitted that in order to create another business pillar with the level of potency similar to ADRO and MDKA, it will take time. SRTG has reportedly prepared USD 100-150 billion of capital expenditure this year. “The allocation depends on the opportunities seen in the market. Hopefully, in 1-2 years, we will be able to take investment opportunities in those sectors,” he stated during the Public Expose of SRTG earlier today (15/5).

SRTG is known to have divested its entire portion in Primaya Hospital managing company, PT Famon Awal Bros Sedaya Tbk (PRAY), two months ago, after successfully promoting its growth. According to Wirawan, at the end of SRTG’s investment period, the hospital has established 16 units of hospitals, proliferating from the initial 4 units. (ZH)